Revolution Medicines (RVMD) said late Tuesday it has priced an offering of 14.1 million shares at $46 per share and pre-funded warrants to purchase 2.2 million shares at $45.9999.
The company also said it has granted underwriters a 30-day option to purchase up to 2.4 million additional shares.
The gross proceeds from the offering, scheduled to close on Thursday, are expected to be about $750 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。